Information Provided By:
Fly News Breaks for May 9, 2019
TRHC
May 9, 2019 | 05:23 EDT
Piper Jaffray analyst Sean Wieland raised his price target for Tabula Rasa HealthCare to $78 from $73 saying the company in Q1 beat on revenue, EBITDA, and earnings, reiterated full-year guidance, and increased long-term gross margin targets by 500 basis points. The recent PrescribeWellness acquisition is making strides in improving patient engagement and should drive margin improvements, Wieland tells investors in a research note. The analyst reiterates an Overweight rating on Tabula Rasa HealthCare.
News For TRHC From the Last 2 Days
There are no results for your query TRHC